Sodium metabisulphite
Rating : 5.5
Evaluation | N. Experts | Evaluation | N. Experts |
---|---|---|---|
1 | 6 | ||
2 | 7 | ||
3 | 8 | ||
4 | 9 | ||
5 | 10 |
Pros:
Preservative (1)Cons:
Specific allergy (1)16 pts from FRanier
Sign up to vote this object, vote his reviews and to contribute to Tiiips.Evaluate | Where is this found? |
"Sodium metabisulfite, studies" about Sodium metabisulphite Review Consensus 8 by FRanier (9976 pt) | 2019-Feb-17 11:37 |
Read the full Tiiip | (Send your comment) |
The sodium metabisulfite (Sodium metabisulfite description) treatment was highly effective in maintaining the integrity and freshness of fruit and vegetable discards, suppressing microbial proliferation, and preserving the nutrient constituents. Under the conditions of this study, sodium metabisulfite effectively preserved fruit and vegetable discards in an aerobic environment, enabling their more efficient long-term recycling through livestock feed or development of value-added products (1).
This study aimed to evaluate the effect of the application of sodium metabisulfite (SMB) on the bond strength of bleached teeth. The use of 25% SMB gel immediately after bleaching was able to reverse the deleterious effect of bleaching on the bond strength of dental composites to dentin (2).
Calcinosis cutis is a chronic calcium-mediated disease that causes significant morbidity. Multiple treatments have been tried, with varying results; indeed, to date, no standard treatment has been generally accepted. Sodium metabisulfite is an inorganic compound that, when it reacts with oxygen, becomes sodium sulfate, a metabolite of sodium thiosulfate that has a similar ability to inhibit calcium oxalate agglomeration. Four women diagnosed with calcinosis cutis, secondary to dermatomyositis, systemic sclerosis and radiodermatitis after breast cancer, were evaluated for their response to topical 25% sodium metabisulfite. In all patients a decrease in lesion size, erythema and pain from injuries was shown, with complete resolution of the associated ulcers. One patient had a complete response. None experienced adverse effects. Topical sodium metabisulfite is a promising emerging therapy that should be considered as a valid alternative treatment in calcinosis cutis. Randomized prospective studies are required to evaluate its true efficacy (3).
References_______________________________
(1) Preservation of fruit and vegetable discards with sodium metabisulfite.
Ahmadi F, Lee YH, Lee WH, Oh YK, Park KK, Kwak WS.
J Environ Manage. 2018 Oct 15;224:113-121. doi: 10.1016/j.jenvman.2018.07.044. Epub 2018 Jul 20
(2) Effect of sodium metabisulfite gel on the bond strength of dentin of bleached teeth.
Vieira HH, Toledo JC Jr, Catelan A, Gouveia THN, Baggio Aguiar FH, Lovadino JR, Leite Lima DAN.
Eur J Dent. 2018 Apr-Jun;12(2):163-170. doi: 10.4103/ejd.ejd_165_17.
(3) Topical sodium metabisulfite for the treatment of calcinosis cutis: a promising new therapy. Del Barrio-Díaz P, Moll-Manzur C, Álvarez-Veliz S, Vera-Kellet C. Br J Dermatol. 2016 Sep;175(3):608-11. doi: 10.1111/bjd.14412. Epub 2016 Apr 17.
Sign up to vote this object, vote his reviews and to contribute to Tiiips.EvaluateClose | (0 comments) |
"Descrizione" about Sodium metabisulphite Review Consensus 16 by FRanier (9976 pt) | 2023-Nov-26 12:33 |
Read the full Tiiip | (Send your comment) |
Sodium metabisulphite is the sodium salt of sulphurous acid, a chemical compound that belongs to the sulphite group, sulphur-based components that release sulphur dioxide SO2, an active preservative compound.
Sodium Metabisulphite is an inorganic compound formed by the combination of sodium ions and metabisulphite. It is commonly used as a preservative and antimicrobial agent in various foods and beverages, as well as a bleaching agent in some industrial applications.
"Metabisulphite" refers to the group of metabisulphite anions (SO2), which are reducing agents and preservatives. "Sodium" indicates the presence of sodium ions (Na+), which bind to the metabisulphite anions to form the compound.
Raw materials used in production and their funcions
Sodium Bisulphate: A sodium salt of sulfurous acid, it acts as the base for the production of sodium metabisulphite.
Sulfur Dioxide (SO2): A gas that reacts with sodium bisulphate to form sodium metabisulphite.
Industrial Chemical Synthesis of Sodium Metabisulphite
It appears as a stable white crystalline powder with a slight odour of sulphur dioxide. Soluble in water. Incompatible with strong oxidising agents, strong acids. On contact with strong acids it releases a poisonous gas.
The sulphite group includes:
Sulphur dioxide | E220 | SO2 |
Sodium sulphite | E221 | Na2SO3 |
Sodium hydrogen sulphite | E222 | NaHO3S |
Sodium metabisulphite | E223 | Na2O5S2 |
Potassium metabisulphite | E224 | K2O5S2 |
Calcium sulphite | E226 | CaSO3 |
Calcium hydrogen sulphite | E227 | CaH2O6S2 |
Potassium hydrogen sulphite | E228 | KHSO3 |
What it is used for and where
Food
It is a preservative, used by the food industry and labelled with the number E223 on the European Food Additives List.
It is used in foods as a bleaching agent and to prevent browning reactions (1).
Cosmetics
It is a restricted ingredient III/99 and V/9 a Relevant Item in the Annexes of the European Cosmetics Regulation 1223/2009
Antioxidant agent. Ingredient that counteracts oxidative stress and prevents cell damage. Free radicals, pathological inflammatory processes, reactive nitrogen species and reactive oxygen species are responsible for the ageing process and many diseases caused by oxidation.
Preservative. Any product containing organic, inorganic compounds, water, needs to be preserved from microbial contamination. Preservatives act against the development of harmful microorganisms and against oxidation of the product.
Reducing agent. Ingredient that facilitates permanent hair waving by adjusting the pH to an optimal level.
Safety
It has been declared a safe component for human health since 1959 (Gunnison and Jacobsen, 1987; Kencebay et al.2013).
Episode of allergic contact dermatitis caused by a catheter system containing sodium metabisulphite (2).
Symptoms attributable to sulphite sensitivity can be of varying nature and importance. The most common are headache and generalised itching or swelling, but cases of nausea, bronchoconstriction, diarrhoea, hypotension and shock have also occurred (3).
EFSA's Scientific Panel on Food Additives and Flavourings assessed the risk for toxic elements in sulphur dioxide (E 220-228), based on data submitted by stakeholders, and concluded that the EU specification maximum limits for arsenic, lead and mercury should be lowered and a maximum limit for cadmium should be introduced (4).
Ophthalmic allergen (5).
Other uses
Caratteristiche tipiche del prodotto commerciale Sodium metabisulfite
Appearance | White powder |
pH | 4.0-4.6 |
Melting Point | 150°C |
Density | 1.48 |
PSA | 189.898254 |
LogP | 0.27220 |
Water Solubility | 540 g/L (20 ºC) |
Water insoluble | 0.01% max |
Fe | 0.002% max |
As | 0.00006% max |
Heavy Metals(Pb) | 0.0003% max |
Safety |
Synonyms
References________________________________________________________________
(1) Dalefield RR, Mueller U. Gastric mucosal irritation following oral exposure to sodium metabisulphite: A reproducible effect? Regul Toxicol Pharmacol. 2016 Oct;80:277-82. doi: 10.1016/j.yrtph.2016.07.005.
(2) Grosch E, Mahler V. Allergic contact dermatitis caused by a catheter system containing sodium metabisulfite. Contact Dermatitis. 2017 Mar;76(3):186-187. doi: 10.1111/cod.12675.
(3) Gunnison AF, Jacobsen DW. Sulfite hypersensitivity. A critical review. CRC Crit Rev Toxicol. 1987;17(3):185-214. doi: 10.3109/10408448709071208.
Abstract. Sulfiting agents (sulfur dioxide and the sodium and potassium salts of bisulfite, sulfite, and metabisulfite) are widely used as preservatives in foods, beverages, and pharmaceuticals. Within the past 5 years, there have been numerous reports of adverse reactions to sulfiting agents. This review presents a comprehensive compilation and discussion of reports describing reactions to ingested, inhaled, and parenterally administered sulfite. Sulfite hypersensitivity is usually, but not exclusively, found within the chronic asthmatic population. Although there is some disagreement on its prevalence, a number of studies have indicated that 5 to 10% of all chronic asthmatics are sulfite hypersensitive. This review also describes respiratory sulfur dioxide sensitivity which essentially all asthmatics experience. Possible mechanisms of sulfite hypersensitivity and sulfur dioxide sensitivity are discussed in detail. Sulfite metabolism and the role of sulfite oxidase in the detoxification of exogenous sulfite are reviewed in relationship to the etiology of sulfite hypersensitivity.
(4) EFSA Panel on Food Additives and Flavourings (FAF); Younes M, Aquilina G, Castle L, Engel KH, Fowler PJ, Frutos Fernandez MJ, Fürst P, Gundert-Remy U, Gürtler R, Husøy T, Manco M, Mennes W, Moldeus P, Passamonti S, Shah R, Waalkens-Berendsen I, Boon P, Cheyns K, Crebelli R, FitzGerald R, Lambré C, Mirat M, Ulbrich B, Vleminckx C, Mech A, Rincon AM, Tard A, Horvath Z, Wright M. Follow-up of the re-evaluation of sulfur dioxide (E 220), sodium sulfite (E 221), sodium bisulfite (E 222), sodium metabisulfite (E 223), potassium metabisulfite (E 224), calcium sulfite (E 226), calcium bisulfite (E 227) and potassium bisulfite (E 228). EFSA J. 2022 Nov 24;20(11):e07594. doi: 10.2903/j.efsa.2022.7594.
Abstract. Sulfur dioxide-sulfites (E 220-228) were re-evaluated in 2016, resulting in the setting of a temporary ADI of 0.7 mg SO2 equivalents/kg bw per day. Following a European Commission call for data, the present follow-up opinion assesses data provided by interested business operators (IBOs) and additional evidence identified in the publicly available literature. No new biological or toxicological data addressing the data gaps described in the re-evaluation were submitted by IBOs. Taking into account data identified from the literature search, the Panel concluded that there was no substantial reduction in the uncertainties previously identified in the re-evaluation. Therefore, the Panel considered that the available toxicity database was inadequate to derive an ADI and withdrew the current temporary group acceptable daily intake (ADI). A margin of exposure (MOE) approach was considered appropriate to assess the risk for these food additives. A lower confidence limit of the benchmark dose of 38 mg SO2 equivalents/kg bw per day, which is lower than the previous reference point of 70 mg SO2 equivalents/kg bw per day, was estimated based on prolonged visual evoked potential latency. An assessment factor of 80 was applied for the assessment of the MoE. At the estimated dietary exposures, when using a refined exposure scenario (Data set D), MOEs at the maximum of 95th percentile ranges were below 80 for all population groups except for adolescents. The dietary exposures estimated using the maximum permitted levels would result in MOEs below 80 in all population groups at the maximum of the ranges of the mean, and for most of the population groups at both minimum and maximum of the ranges at the 95th percentile. The Panel concluded that this raises a safety concern for both dietary exposure scenarios. The Panel also performed a risk assessment for toxic elements present in sulfur dioxide-sulfites (E 220-228), based on data submitted by IBOs, and concluded that the maximum limits in the EU specifications for arsenic, lead and mercury should be lowered and a maximum limit for cadmium should be introduced.
(5) Herbst RA, Uter W, Pirker C, Geier J, Frosch PJ. Allergic and non-allergic periorbital dermatitis: patch test results of the Information Network of the Departments of Dermatology during a 5-year period. Contact Dermatitis. 2004 Jul;51(1):13-9. doi: 10.1111/j.0105-1873.2004.00334.x.
Abstract. Periorbital dermatitis is common and can be due to the external use of ophthalmic drugs. We evaluated patch test results of the Information Network of the Departments of Dermatology. During a 5-year period (1995-99), of a total 49,256 patch-tested patients, 1053 (2.1%) were eventually diagnosed as allergic periorbital contact dermatitis (APD) and 588 (1.2%) as non-allergic periorbital dermatitis (NAPD). Patient characteristics between APD, NAPD and other cases (OCs) differed with respect to sex (19.7% male in both periorbital groups versus 36.3% in OCs), atopic dermatitis (10.4% in APD versus 60.2% in NAPD versus 16.9% in OCs) and age, APD being substantially more often (68.2%) aged 40 and above than NAPD (52.6%). Several of the top allergens in OCs [such as fragrance mix, Myroxylon pereirae resin (balsam of Peru), lanolin alcohol and potassium dichromate] caused significantly fewer positive test reactions in both periorbital groups. In contrast, thimerosal, phenylmercuric acetate, sodium disulfite, gentamicin sulfate, phenylephrine hydrochloride and benzalkonium chloride tested positively significantly more often in APD but not in NAPD, verifying them as true ophthalmic allergens. Finally, in 42 cases (4%) of APD patients, additional allergens were identified by testing of the patients' own substances (mostly beta-blockers, oxybuprocaine and dexpanthenol), supporting the necessity of testing with ophthalmic drugs as is where individual substances are not readily available.
Sign up to vote this object, vote his reviews and to contribute to Tiiips.EvaluateClose | (0 comments) |
Read other Tiiips about this object in __Italiano (2)
Component type:   Chemical Main substances:   Sulphurous acid Last update:   2024-03-27 18:40:52 | Chemical Risk:   |